Shishkaberry from CanPoland: lineage from Blueberry and a single-source profile

What is Shishkaberry and where does this strain come from?

Shishkaberry is a hybrid with a documented lineage: a cross between the DJ Short Blueberry line and an unspecified Afghan strain, attributed to a breeder signing as Breeder Steve and the seed company Spice of Life Seeds, dated 1996. It reached Polish pharmacies as a single entry from one producer.

The lineage is only partially known, and that part has a proper name. DJ Short Blueberry is a specific breeding line managed under the breeder's name, so it can be pointed out. The other parent is listed in the source as an unknown Afghan strain, which serves as a label for an entire group of plants from a single cultivation region. Such a record does not indicate a specific plant, only the area from which it originated.

The lineage record has two supports in our case. The first is the Leafly database, which states the crossing of the DJ Short Blueberry line with an unspecified Afghan strain and links it to the breeder and the year 1996. The second is the Polish list of medicinal strains, describing the raw material from the producer CanPoland under the same name. The second support confirms the presence of the name in the pharmaceutical trade, but does not clarify the origin of the plant.

In strain descriptions, two things usually merge: the breeding name and the pharmaceutical entry. The breeding name comes from the nineties and describes the genetics of the seed. The pharmaceutical entry is the raw material from a specific producer, harvested in a specific cultivation cycle, with its own batch number. The consistency of the names alone does not guarantee that the plant under this label in two countries has undergone the same history.

How many producers supply this strain to Polish pharmacies?

One. In our list of pharmaceutical entries, Shishkaberry has exactly one entry, and it is from CanPoland. The registered name starts with the formula Cannabis flos and ends with the producer's designation, and we intentionally omit the numerical part in the middle, the reason for which we describe below.

The numerical part in the registered name appears to be a measurement, but it is a declaration. The producer provides a nominal value, from which deviations are allowed, and only the pair of these two pieces of information describes anything. For this entry, our source provides only the nominal value, without deviation, so rewriting it here would mean pretending to have precision that is not present in the data. Therefore, it will not appear in this text even once.

One producer changes the situation at the pharmacy counter more significantly than it appears on paper. With a name managed by four producers, the absence of one entry in the wholesale can be compensated by another with the same name. Here, there is no such substitute: the producer disappears, the name disappears.

The presence of a name in the pharmacy is not a permanent state and changes faster than the text about the strain. Behind each entry stands a permit with its own expiration date, a distribution agreement, and a cultivation cycle counted in months. It is enough for one of these links to fall out, and the name disappears from the list without announcement. The database from which we take the composition of this strain marks its position as withdrawn. We maintain the current state exclusively in the compilation of available strains, because only there can it be updated monthly. We separately describe the producer itself and the second strain, which dostarcza.

What does Shishkaberry smell and taste like?

Unknown. The only source describing this strain leaves the aroma section blank, so no scent or taste is documented here. However, it fills in the composition section, and that is all that can be said about the aroma of this strain without guessing based on the compounds alone.

The composition section lists four entries for this strain: myrcene, caryophyllene, limonene and ocymen. The compilation comes from a single source, as the second database we use in this cluster does not describe this strain at all. With one description, there is nothing to compare it to, so there is also no signal confirming that the composition was measured correctly.

Next to the names, the source provides shares, but we do not transcribe them, and in this case, the reason is clear. The four numbers given for Shishkaberry add up to 101, which is more than the whole. Since the sum exceeds one hundred, the denominator is not the set of all terpenes in the raw material, but something else that the source does not name. A number without a known denominator measures nothing, yet it appears to be a measurement. In the entire database, there are six such entries out of 145 described, with a median sum of 82.

More is known about the scent of the compounds themselves than about the scent of this strain. Myrcene is often described as earthy and herbal, caryophyllene as peppery, limonene as citrusy, and ocimene as sweet with a woody note. However, combining these descriptions into one description of the strain would be guesswork: the proportions remain unknown, and the aroma of the dried flower also depends on drying and storage, not just on what the analysis showed.

How long does it take for this strain to take effect, and how long does the effect last?

It does not depend on the strain, but on the method of administration. No concentration measurements in the blood have been published for Shishkaberry, so the ranges below describe the inhalation and oral intake of dried flower in general, and the cultivar name does not change anything in them. The same course applies to every other entry in this list.

The route of administration determines the course more than the variety itself. After vaporization, the substance passes from the lungs to the blood almost immediately, so the first sensations appear after a few minutes, the intensity increases for another ten to thirty minutes, and the whole effect lasts for two to four hours. After ingestion, the raw material first passes through the intestine and liver, so the first sensations are awaited from half an hour to two hours, and the episode can last six, sometimes eight hours. Hence the most common mistake with oral administration: anyone who thinks nothing is happening after thirty minutes and takes another dose will receive both doses at once. The above ranges describe the route of administration, not this variety; pharmacokinetic studies for a single cultivar have not been published.

For this entry, there is one more limitation. Since it is backed by a single manufacturer and a narrow supply stream, even if someone measured the course on its raw material, the result would describe that batch, not the label on the package. Measurement is related to the batch of material, not to a breeding label from thirty years ago.

What has been shown about the effects of this strain, and what has not?

Nothing. No study has examined Shishkaberry as a cultivar, so nothing has been shown about the effects of this specific strain. The studies concern a single compound, myrcene, which has the highest share in the only published profile here, and they were conducted on mice, not on patients with prescriptions. We have three such studies in the evidence base of this cluster.

All three must be read together with their model, as the direction of the result changes with the method of administration and the sex of the animals. The following compilation presents them in the order of their creation, along with what each of them showed.

Doses were administered in milligrams per kilogram of mouse body weight, and in two of the three studies by injection into the peritoneal cavity. Translating such a dose into one puff of vapor from dried flower is not arithmetic, and no one has published such a conversion. Separately, what is not studied: popular databases attribute balanced effects to this name, and commercial descriptions repeat this label without indicating where it came from.

In humans, myrcene alone has not been shown to alleviate insomnia at doses typical for inhalation of dried flower. The direction of the effect in rodents depends on the route of administration and sex: intraperitoneal injection in 2002 described a slightly anxiogenic effect, while inhalation in 2024 showed an anxiolytic effect in females. These two results do not negate each other; they simply show that the conclusion depends on conditions that no popular strain database provides.

What side effects have been reported for this strain?

None under this name. Public safety compilations do not go down to the level of cultivar, so the question about symptoms after Shishkaberry has no data-based answer. Therefore, below is what has been documented for dried flower in general, and we directly indicate where these observations come from.

Reports of adverse effects are collected for medicinal products with a batch number, not for the strain name, so the following pertains to hemp dried flower as a group of raw materials. The most frequently reported symptoms are dry mouth, red eyes, and increased heart rate. Dizziness upon rapid standing, daytime drowsiness, and temporary worsening of short-term memory are less frequently described, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for hemp dried flower in Poland do not separate them by individual products.

For this entry, there is one more reason why numbers will not be generated. A single manufacturer and narrow presence in circulation mean that even if reports were separated by breeding names, the sample would be too small to count anything from it.

Is it possible to adjust the vaporization temperature for this strain?

No, and not due to a lack of equipment. The method of consuming the raw material is determined by the attending physician, and the numbers that popular tables refer to are not comparable for the four compounds in this profile, as they come from measurements taken at different pressures or without specifying pressure at all.

The boiling point is often presented as a threshold, beyond which the compound begins to vaporize, and this is a misunderstanding. Vaporization occurs much lower, and its rate increases exponentially with temperature. The boiling point is the moment when the vapor pressure equals the surrounding pressure, so without the given pressure, the number itself says nothing. The entire popular targeting of a chosen terpen opiera is based on this confusion of threshold with condition.

Hence the caution regarding such tables. For three compounds from this profile, the database provides measurements referenced to atmospheric pressure, while for ocimene, it gives just the number, without information about conditions. Setting four values in one column would suggest that they can be compared, but that is precisely what cannot be done. We outline this separately, in the context of questions about the comparability of popular temperature tables.

This section describes the state of knowledge about the compounds themselves. It is not a recommendation, does not refer to any device, and does not replace the arrangements made with the attending physician.

Which strains from Polish pharmacies are related to it?

None. In this data, Shishkaberry is on the side of the descendant, not the parent: it is not in the pedigree of any other pharmacy position from this cluster. On the parent side, it has the DJ Short Blueberry line and an Afghan strain, and the latter is the name of a family, not a single plant.

Searching the pedigrees of all 85 cultivars from this compilation shows not a single entry that has Shishkaberry among its parents. Therefore, this strain does not have descendants in Polish pharmacies, and we simply will not find entries stating otherwise in the data.

The common parent is shared with two entries from the same list, and that does not prove anything. Blueberry oraz L.A Confidential have an Afghan strain in their pedigree, just like ours. However, the Afghan strain remains the name of a family of plants from one region, not a plant that could be identified, so the two cultivars sharing such an entry are not siblings. The same mechanism applies to entries like haze or og kush.

The name does not help either. The term berry is carried in this listing, besides our entry, by four others: Blueberry, Northern Berry, Sweet Berry Kush and Strawberry OG. The lineages diverge completely: Sweet Berry Kush descends from banana og and purple punch, while Strawberry OG comes from bruce banner number 3 and sfv og ibl. The only interesting case here is Northern Berry, which has blueberry listed among its parents, while we have dj short blueberry recorded. In this database, these are two different strings, so the graph does not connect them and does not derive siblings from them. Determining whether this refers to the same breeding line would require a source that is not available here, and adding it based on intuition would create a false link between the two entries.

Frequently Asked Questions about the Shishkaberry strain

Is Shishkaberry currently available in Polish pharmacies?

The answer changes from month to month, which is why we only maintain the current status in the list of available strains, not in this text. The database describing the composition of this strain indicates its status as withdrawn.

How many producers supply this strain?

One. In our list of pharmaceutical positions, Shishkaberry appears once and is supplied by CanPoland.

Why don't you provide the active substance content for this strain?

Because the source does not provide the deviation within which the declared number falls. The nominal value without this deviation suggests a precision that is not present in the data, so we also omit it in the registration name.

Which compound has the largest share in the profile of this strain?

Myrcene. The only source describing the composition places it first, ahead of ocimene, caryophyllene, and limonene.

Does Shishkaberry have siblings among pharmaceutical strains?

No. No other position from this cluster shares an identified parent with it, and the common entry about the Afghan strain is the name of a plant family, not a single plant.

Do studies on myrcene say anything about the effects of this strain in humans?

No. All three studies from the evidence base of this cluster were conducted on mice, and doses were administered in milligrams per kilogram of body weight of the animal or as short inhalations of vapor.

Dried flower is a pharmaceutical raw material dispensed by prescription in the Rpw category. The material is for informational purposes only and does not replace medical advice nor constitutes encouragement to purchase. The dried flower offered in our store, in the category drought, is a different product than the pharmaceutical raw material and is not subject to this dispensing procedure.

Editorial text: ubocha.